Kurs & Likviditet
Kalender
2024-10-30 | Kvartalsrapport 2024-Q3 |
2024-07-17 | Kvartalsrapport 2024-Q2 |
2024-04-24 | Kvartalsrapport 2024-Q1 |
2024-04-12 | Ordinarie utdelning BRG 3.75 NOK |
2024-04-11 | Årsstämma 2024 |
2024-01-31 | Bokslutskommuniké 2023 |
2023-10-24 | Kvartalsrapport 2023-Q3 |
2023-07-18 | Kvartalsrapport 2023-Q2 |
2023-05-03 | Kvartalsrapport 2023-Q1 |
2023-04-19 | Ordinarie utdelning BRG 3.25 NOK |
2023-04-18 | Årsstämma 2023 |
2023-02-02 | Bokslutskommuniké 2022 |
2022-10-21 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-05-03 | Kvartalsrapport 2022-Q1 |
2022-04-08 | Ordinarie utdelning BRG 2.75 NOK |
2022-04-08 | Bonusutdelning BRG 2.25 |
2022-04-07 | Årsstämma 2022 |
2022-02-03 | Bokslutskommuniké 2021 |
2021-10-21 | Kvartalsrapport 2021-Q3 |
2021-07-15 | Kvartalsrapport 2021-Q2 |
2021-04-28 | Kvartalsrapport 2021-Q1 |
2021-04-15 | Ordinarie utdelning BRG 2.50 NOK |
2021-04-14 | Årsstämma 2021 |
2021-02-03 | Bokslutskommuniké 2020 |
2020-10-21 | Kvartalsrapport 2020-Q3 |
2020-07-16 | Kvartalsrapport 2020-Q2 |
2020-06-16 | Ordinarie utdelning BRG 2.30 NOK |
2020-06-15 | Årsstämma 2020 |
2020-04-29 | Kvartalsrapport 2020-Q1 |
2020-02-05 | Bokslutskommuniké 2019 |
2019-10-18 | Kvartalsrapport 2019-Q3 |
2019-07-16 | Kvartalsrapport 2019-Q2 |
2019-04-30 | Kvartalsrapport 2019-Q1 |
2019-04-12 | Ordinarie utdelning BRG 2.25 NOK |
2019-04-11 | Årsstämma 2019 |
2019-01-31 | Bokslutskommuniké 2018 |
2018-10-23 | Kvartalsrapport 2018-Q3 |
2018-07-17 | Kvartalsrapport 2018-Q2 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-04-13 | Ordinarie utdelning BRG 2.00 NOK |
2018-04-12 | Årsstämma 2018 |
2018-02-02 | Bokslutskommuniké 2017 |
2017-10-24 | Kvartalsrapport 2017-Q3 |
2017-07-18 | Kvartalsrapport 2017-Q2 |
2017-05-03 | Kvartalsrapport 2017-Q1 |
2017-04-21 | Bonusutdelning BRG 1.75 |
2017-04-21 | Ordinarie utdelning BRG 1.75 NOK |
2017-04-20 | Årsstämma 2017 |
2017-02-10 | Bokslutskommuniké 2016 |
2016-10-21 | Kvartalsrapport 2016-Q3 |
2016-09-20 | Kapitalmarknadsdag 2016 |
2016-07-18 | Kvartalsrapport 2016-Q2 |
2016-04-27 | Kvartalsrapport 2016-Q1 |
2016-04-14 | Ordinarie utdelning BRG 1.50 NOK |
2016-04-13 | Årsstämma 2016 |
2016-02-03 | Bokslutskommuniké 2015 |
2015-10-21 | Kvartalsrapport 2015-Q3 |
2015-07-15 | Kvartalsrapport 2015-Q2 |
2015-04-28 | Kvartalsrapport 2015-Q1 |
2015-04-16 | Ordinarie utdelning BRG 1.25 NOK |
2015-04-15 | Årsstämma 2015 |
2015-02-04 | Bokslutskommuniké 2014 |
2014-10-22 | Kvartalsrapport 2014-Q3 |
2014-07-16 | Kvartalsrapport 2014-Q2 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-04-24 | Ordinarie utdelning |
2014-04-23 | Årsstämma 2014 |
2014-03-11 | Kapitalmarknadsdag 2014 |
2014-02-05 | Bokslutskommuniké 2013 |
2013-10-29 | Kvartalsrapport 2013-Q3 |
2013-07-17 | Kvartalsrapport 2013-Q2 |
2013-04-30 | Kvartalsrapport 2013-Q1 |
2013-04-16 | Ordinarie utdelning |
2013-04-15 | Årsstämma 2013 |
2013-02-06 | Bokslutskommuniké 2012 |
2013-01-10 | Extra Bolagsstämma 2013 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Material |
Industri | Plast, kemikalier & fetter |
Borregaard will co-invest with the European Innovation Council Fund and several other public and private investors in a direct offering of new shares in the Danish bioscience company Kaffe Bueno ApS. In total, Kaffe Bueno will raise EUR 6.2 million in new capital from the direct offering. After the transaction, Borregaard will hold 12% of the shares in Kaffe Bueno, with an investment of EUR 3 million.
Borregaard has been granted warrants to subscribe for additional shares in Kaffe Bueno on or before 31 January 2026. If exercised in full, these warrants will bring Borregaard’s ownership share up to 34% and contribute another EUR 9.25 million in equity to Kaffe Bueno.
From coffee by-products, Kaffe Bueno derives active and functional ingredients which can be applied in a wide range of consumer and industrial products, including personal care, human nutrition, and agriculture. Through the described equity transactions, Kaffe Bueno has secured the necessary funding to complete the construction of their 500 tonnes per year biorefinery in the Copenhagen area. Furthermore, the funding will allow Kaffe Bueno’s first commercial volumes to the market and continued development of their product portfolio.
Sarpsborg, 22 December 2023
Contacts:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
Director Communications, Tone Horvei Bredal, +47 924 67 711
This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.